SRPT
Sarepta Therapeutics
NASDAQ: SRPT · Cambridge, MA · Healthcare
$15.68-0.20 (-1.26%)Closed
Market Cap$11.40B
Cash$1.13Bmost recent
Runway18 mo$155.0M Q burn
P/E (TTM)—EPS $-2.45
52-Wk Range$11.93 – $24.45
Avg Volume5.0M3-month
Healthstable
Genetic medicine company focused on Duchenne muscular dystrophy and other rare neuromuscular diseases.
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$15.68-89.4%
Pipeline
Drug candidates sponsored by SRPT · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
Gene therapy · rare disease · 4 tickers
Loading peers…
Cells tinted green are top-ranked in the cohort, red are worst-ranked.